Showing results (261-270 of 438) with videos related to

Sort By:
Pageof 44
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantationAjay K Nooka, Heather R Johnson, Jonathan L Kaufman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin LymphomaJonathon B Cohen, Silvana Bucur, Elliott F Winton, et al.
American Journal of Hematology|May 31, 2022
Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populationsWilson L da Costa, Danielle Guffey, Abiodun Oluyomi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding studySagar Lonial, Jonathan Kaufman, Mourad Tighiouart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare studyJonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.
Leukemia & Lymphoma|June 19, 2018
Deferred treatment is a safe and viable option for selected patients with mantle cell lymphomaOscar Calzada, Jeffrey M Switchenko, Joseph J Maly, et al.
Blood Advances|April 12, 2024
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHLChijioke Nze, Clark R Andersen, Amy A Ayers, et al.
Blood|September 28, 2019
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaMatthew Lunning, Julie Vose, Loretta Nastoupil, et al.
American Journal of Hematology|April 17, 2023
External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer centerAng Li, Giordana De Las Pozas, Clark R Andersen, et al.
Pageof 44